Genetic test for heart disease nears launch
This article was originally published in Clinica
A genetic susceptibility test for heart disease could be available in the US within a year. Medical Science Systems of Newport Beach, California, has linked up with the Mayo Clinic in Rochester, Minnesota, to determine how the genetic marker identified by the test interacts with other factors to produce heart disease. The marker is known to influence the inflammatory component of the disease.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.